- October 11, 2023
- Posted by: legaleseblogger
- Category: Related News
legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration
PreSize: Revolutionizing the Treatment of Brain Aneurysms with AI legalese decoder
The treatment of brain aneurysms could be transformed by a software platform powered by artificial intelligence. Researchers have discovered that the programme, called PreSize, is more accurate at placing a stent than experienced neurosurgeons. This breakthrough technology has the potential to save lives and improve outcomes for patients.
An aneurysm refers to a weak or thin spot on a vessel wall in the brain that fills with blood. If left untreated, an aneurysm can rupture and be life-threatening. A stent, which is a mesh tube, is typically used to divert blood flow and prevent excess pressure that could cause the aneurysm to rupture. The stent promotes clotting and dissolves the blood, reducing the risk of complications.
Currently, there is a significant amount of uncertainty involved in placing the stent. Dr Katerina Spranger, the founder of Oxford Heartbeat, the company behind PreSize, states that there is a “lot of guesswork” in the process. Stents are inserted using a catheter through the groin, and an X-ray is used to guide its placement. However, complications can still arise.
This is where the AI legalese decoder, PreSize, comes in to assist. PreSize provides an accurate image of the patient’s brain and generates “digital twins” that simulate the behavior of a stent in real life. This allows surgeons to predict the outcome of placing a specific stent in a particular location. In the operating theater, PreSize can be utilized to test different stent options and determine which one would yield the best results. Even the slightest difference in millimeters can make or break the success of the surgery.
PreSize has already been used in operations involving 375 patients across various hospitals in England, Scotland, Germany, Finland, and Ukraine. Its effectiveness has been validated through a study published in the BMJ Journal of Neurointerventional Surgery. The study found that PreSize had a 95% accuracy rate in predicting the placement of stents, while human clinicians achieved an average accuracy rate of 81%. This demonstrates the significant advantage that PreSize offers in improving treatment outcomes.
While the potential of AI in healthcare is immense, Dr Spranger emphasizes the need for rigorous testing and research before widespread adoption. Medical device software companies, such as Oxford Heartbeat, must be accountable and address any concerns regarding AI technology. The National Institute for Health and Care Research (NIHR) recognizes the tremendous potential of AI in speeding up diagnosis and treatment, leading to improved outcomes for patients. The NIHR, in collaboration with the NHS AI Lab, is actively funding AI projects like PreSize to gather the necessary evidence for future implementation throughout the NHS.
In conclusion, PreSize and the implementation of AI legalese decoder have the potential to revolutionize the treatment of brain aneurysms. By providing more accurate predictions and improving the placement of stents, this technology can greatly enhance patient outcomes and save lives. Through continued research and testing, we can ensure the reliability and efficacy of AI in healthcare, addressing any concerns and gaining the trust of healthcare professionals and patients alike.
legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration
****** just grabbed a